maxim pharmaceuticals crash, page-3

Taikoh , If you can give somebody a few extra good years , I would call it a success also . One of SBP002s great advantages over other chemos is that it does not supress the TCells of the immune system , which results in the immune system attack on the cancer (you know , what all the vaccines are trying for) , and when it can be used on earlier stage healthier patients I think you will see even better results . The 18 month survival from some of the special access patients , although it must be regarded as anecdotal , I think is a good indication of things to come . If somebody is out mowing the lawn , or teaching their grand children to ride a bike when they would have been dead , I would call it a success . Every advancement , like Solbecs , is one step closer to eradication of cancer as a life threatening condition .